Picture of Vivos Therapeutics logo

VVOS — Vivos Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Vivos jumps as device maker partners with SoundHealth to broaden sleep, allergy offerings

** Shares of Medical device maker Vivos Therapeutics VVOS.O rise 10% to $1.65 premarket

** Co says it will distribute SoundHealth’s sleep and allergy devices, including an FDA-cleared wearable for nasal congestion and a new band that uses sound-based therapy to help users sleep

** Partnership also gives Vivos access to facial‑scanning and voice‑analysis tools to help screen patients for sleep disorders, per co

** Collaboration aims to widen access to non‑invasive treatments for sleep‑related breathing issues, which are often undiagnosed, co says

** Vivos develops devices for sleep apnea; SoundHealth builds AI‑powered health tools

** Shares down ~53% in 2025

 (Reporting by Sahil Pandey in Bengaluru)

 ((Sahil.Pandey@thomsonreuters.com))

Recent news on Vivos Therapeutics

See all news